发展历程

可以获取正确的诊断成像，以便医师选择最合适的诊疗方案。

我们的专家小组讨论了放射学和精密成像如何在AI大有可为的领域中发挥作用。

环境可持续性和可持续未来意味着什么？我们的专家小组试图制定一个解决方案框架。

揭开Fulvia和Diana Bracco的创业历程。

探索博莱科如何从创立伊始，就努力纠正性别失衡问题。

了解博莱科如何呵护我们的后代和美丽的地球。

探索一家布局未来的公司，曾走过的峥嵘岁月。数以千计的文件、照片、技术图纸和广告为您的浏览平添乐趣。

探索我们的传统和员工如何让博莱科发展壮大——并发现未完待续的故事。

博莱科影像播客：专业意见、当前趋势、未来展望。

An insight interview with our Chief Medical and Regulatory Officer, Alberto Spinazzi, MD.

Intervista con Fabio Tedoldi, Head of Bracco Global R&D

Hear it from Stefania Bollini, Global Product Manager at Bracco.

The Residency Program that champions the next generation of radiology leaders.

Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.

Closing the gender gap and designing inclusive economic recovery, in all fields, is what our society needs. The percentage of women in radiology is increasing in the younger age groups: what is changing?

GUESTS: Elisabetta Trinchero, Nicoletta Gandolfo, Anna Simeone, Michaela Cellina, Regina Beets-Tan

HOST: Gaela Bernini

Interview with our Global Sales Operations Manager, Enrico Licata.

We are thrilled to open the doors of our “digital house” created by our people and inhabited by our stories. We live to improve people’s lives by shaping the future of prevention and precision imaging and through the website we provide a clear message of who we are and what we stand for. Moreover, the many photos, stories, podcasts, and more share who the Bracco People are.

We are pleased to announce we accepted the invitation by the United Nations Global Compact to join this important initiative — a voluntary leadership platform for the development, implementation and disclosure of responsible business practices.

Diagnostic imaging, genomic and proteomic analyses are only some of the main sectors of research that are focused on fulfilling the ultimate goal of precision medicine: administer the right treatment to the right patient at the right time.
But how is the medical imaging evolving thanks to this ultimate attention to the patient?
Technical innovations, such as in vitro and vivo diagnostics, even if operate in two different onsets, are looking into the human body and retrieving information extremely relevant for the medical decision-making process, helping the evolution of personalised and targeted medicine.

The era of “4P” medicine is already here: unstoppable and unavoidable!